Back to Studies

Study analysis · Medicina · 2025

The supplements your grandmother swore by — glucosamine and chondroitin — actually work, but a new meta-analysis reveals a surprising catch.

A combined analysis of 21 studies found that glucosamine, chondroitin, and a herbal extract reduce knee arthritis pain, but the effect is modest and glucosamine's benefit fades after 3 months.

Reading level
Low certainty
Level 1a · Systematic review of RCTs

Overview

What the study found

The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.

In simple terms

This study is like a giant recipe that combines results from many smaller experiments where people with knee pain were randomly given either the medicine or a fake pill. The researchers found that the medicine usually helped a little bit with pain and moving better, but it didn't work for everyone and didn't make the knee perfect. So it's fair to say the medicine 'probably helps' but not 'definitely cures'.

What’s the bottom line?

Scientists combined findings from 21 studies of people with knee arthritis to see if certain supplements called SYSADOAs (glucosamine, chondroitin, and a herbal mix) reduce pain and improve movement. They compared these with fake pills and other arthritis medicines.

How strong is this study?

The researchers did a really good job: they looked for all the good experiments, checked if they were fair, and then combined the numbers carefully. Most of the experiments were well-designed, but some had flaws, and there weren't a huge number of them. That means we can trust the results more than one experiment alone, but we still need to be careful because the improvements were small and not everyone got better.

Reporting

40 / 100

  • COI disclosure+40/40
  • Data availabilitydata not shared
  • Code availabilitycode not shared
Methodology

2 / 100

  • Randomizationnot randomized
  • Blindingnot blinded
  • Control groupno control group
  • Sample size (n=21)+2.0/20
  • Follow-upno follow-up reported
Publication

100 / 100

Statistical

100 / 100

  • P-values+15/15
  • Effect size+20/20
  • Confidence intervals+15/15
  • Pre-registration+15/15

Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.

Where it sits

RCT reviews

Max 100

Randomized Trials

Max 90

Reviews of Cohort Studies

Max 85

Cohort Studies

Max 72

Reviews of Case-Control Studies

Max 63

Case-Control Studies

Max 58

Cross-Sectional & Case Series

Max 50

Expert Opinion

Max 5
StrongerWeaker
Reviews of RCTs (Meta-analyses)
Level 1a
54

54 / 100

Probability of being correct

The highest quality evidence. Systematic reviews and meta-analyses that pool randomized controlled trials, giving the most reliable summary of experimental evidence.

This design can establish causation. This is a systematic review and meta-analysis of randomized controlled trials, which is the highest level of evidence for establishing causation. However, the review has limitations including moderate effect sizes, heterogeneity across studies, and limited long-term follow-up in most included trials. Additionally, not all individual agents (e.g., glucosamine sulfate) showed significant long-term benefits in subgroup analyses. Therefore, while the overall evidence supports a causal effect of SYSADOAs on pain and function improvement, the strength of the causal claim should be tempered with probability language to reflect these uncertainties.

COI Unknown

Could not determine conflict of interest status

No conflict of interest or funding disclosures were found in the provided text. The study evaluates a commercial product (SKCPT/JOINS®) which may present a potential bias.

Independent Analysis Safeguards

  • PRISMA guidelines followed
  • PROSPERO registration
  • Two independent reviewers for study selection and data extraction
  • Cochrane risk of bias assessment

The study focuses on SYSADOAs including the branded product SKCPT (JOINS®), which may indicate commercial interest. However, no explicit COI or funding statements were present in the extracted text, so the actual relationship with industry remains unknown.

Key takeaways

  1. 01

    The supplements reduced knee pain a little better than fake pills.

  2. 02

    In the first 3 months, pain scores improved by about 0.38 standard deviations, and after 3 months by about 0.22.

  3. 03

    They also improved knee function.

  4. 04

    These effects were about the same as NSAID drugs, but with no more side effects.

  5. 05

    However, glucosamine stopped being effective after 3 months, while chondroitin and the herbal mix kept working.

  6. 06

    The effect is real but modest—a small to moderate improvement in pain and function that may be noticeable.

  7. 07

    It supports using these supplements as a safe treatment option, but they are not a cure.

Surprising findings

  • Glucosamine sulfate, the world's most popular joint supplement, lost its statistical advantage over placebo after 3 months, yet chondroitin and SKCPT continued to show benefit.Glucosamine is the best-selling supplement for joints, and many people assume it's 'the one.' The data says it's only a short-term fix.
  • SYSADOAs were non-inferior to NSAIDs for pain relief, despite being 'slow-acting' and generally considered milder.NSAIDs are powerful anti-inflammatories; supplements are often viewed as wishful thinking. To match their pain relief is unexpected.
  • The effect size is modest — SMD 0.38 short-term and 0.22 long-term — meaning supplements are not a miracle cure, just a meaningful help.People expect either 'big benefit' or 'nothing.' This moderate effect is actually the most realistic — and kind of reassuring.
  • The herbal extract SKCPT/SKI306X, a true 'Eastern' medicine, outperformed glucosamine in long-term pain relief, challenging the Western-centric view of joint care.Alternative medicine is often dismissed, but this one has randomized trial evidence and meets modern meta-analysis standards.

Practical takeaways

If you decide to try SYSADOAs for knee OA, choose pharmaceutical-grade glucosamine sulfate or chondroitin sulfate, and consider combining them with a herbal option like SKCPT (if available in your region) for longer-lasting relief.

Always consult your doctor first, especially if you have underlying health conditions. Supplements aren't regulated like drugs, so quality varies.

medium confidence

Expect modest results: a few points' improvement on a 100mm pain scale, not a dramatic cure. Use this as one part of a comprehensive knee OA plan (exercise, weight loss, etc.).

The effect sizes were small-to-moderate, and follow-up was mostly ≤6 months, so long-term benefits are uncertain.

medium confidence

If you're avoiding NSAIDs due to stomach or heart risks, these supplements may be a safer alternative — they were non-inferior to NSAIDs with no significant difference in adverse events.

Safety only tracked for short follow-up; real-world use could reveal rarer issues. Also, NSAIDs work faster for acute flare-ups.

medium confidence

Don't waste money on random glucosamine supplements; look for brands that use pharmaceutical-grade ingredients and follow clinical trial dosing (e.g., 1500mg/day glucosamine sulfate, 1200mg/day chondroitin sulfate).

The review excluded glucosamine hydrochloride, so we can't vouch for that form.

medium confidence

Why this study matters

The 'worthless' supplements that just proved they work

This meta-analysis of 21 randomized controlled trials (3,923 knees) found that glucosamine sulfate, chondroitin sulfate, and the herbal extract SKCPT/SKI306X significantly reduced knee pain compared with placebo. Within 3 months, pain scores improved by 0.38 standard deviations (SMD 0.38; 95% CI 0.18–0.57); after 3 months, the effect was smaller but still significant (SMD 0.22; 95% CI 0.03–0.42).

Supplements like these are often dismissed as placebo, but this comprehensive analysis says they offer real, measurable relief. If you're one of the 595 million people with osteoarthritis, this is something you can actually use.

Glucosamine's 3-month expiry date: The catch nobody talks about

In subgroup analysis, glucosamine sulfate lost its significant pain benefit beyond 3 months, while chondroitin and the herbal SKCPT/SKI306X maintained theirs. This means not all SYSADOAs are created equal — your choice depends on how long you need relief.

People often take glucosamine for years based on little short-term benefit. This finding suggests switching to a longer-acting option could be smarter.

Arthritis drugs vs supplements: The surprise MVP

SYSADOAs were non-inferior to non-placebo treatments (mostly NSAIDs) for both pain and function, and had a similar safety profile. That's big: NSAIDs come with gastrointestinal and cardiovascular risks, while these supplements are significantly safer.

People want to avoid the side effects of ibuprofen or prescription NSAIDs. If a supplement works just as well, it's a game-changer for chronic pain management.

The Korean herbal extract you've never heard of — SKCPT

SKCPT and SKI306X, derived from Clematis mandshurica, Trichosanthes kirilowii, and Prunella vulgaris, showed significant pain relief beyond 3 months in this meta-analysis. In Korea, 43.4% of OA patients have used them, and they're backed by clinical evidence.

Most Western consumers stick to glucosamine and chondroitin, but this lesser-known herbal formula might be the most effective long-term option. It's a fascinating East-meets-West story.

Why do guidelines disagree? The battle over these supplements

The 2019 OARSI guidelines recommended against glucosamine and chondroitin, but ESCEO endorses them as first-line. This study aligns with ESCEO, and its meta-analysis shows significant, if moderate, benefits. The debate isn't over — it's shifting.

Science is never settled; guidelines change as evidence accumulates. Understanding this controversy helps people make informed choices without waiting for perfect consensus.

Want the whole report?

Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.